MedTrace Logo

Standard Operating Procedure As a Valuable Tool to Increase Adherence to Lung Protective Ventilation Among Anesthesiologists.

NCT05831683 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 164

Last updated 2025-02-05

No results posted yet for this study

Summary

Lung Protective Ventilation (LPV) is considered the gold standard of care nowadays. Even though, all over the world reported adherence to this concept, among anesthesiologists, is only 15%. The investigators hypothesized that the introduction of the Standard Operating Procedure (SOP) document will increase adherence to LPV among anesthesiologists. In this study, the investigators will record ventilating parameters during general anesthesia using Care Station Insights software. Then, the investigators will evaluate the recorded parameters and match them with LPV criteria. The adherence level to every parameter separately will be counted in percentage.

Conditions

  • Adherence, Treatment

Interventions

OTHER

Introduction of Standard Operating Procedure regarding lung protective ventilation during general anaesthesia.

The Standard Operating Procedure document will be introduced. The SOP document will cover the theoretical background, definition, and recommendations/criteria of LPV. The SOP document will reflect the most recent LPV guidelines.

Sponsors & Collaborators

  • Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.

    lead OTHER

Principal Investigators

  • Michal Kalina, MUDr. · Krajská Zdravotní a.s. Klinika anesteziologie, perioperační a intenzivní medicíny MNUL a FZS UJEP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-20
Primary Completion
2023-06-11
Completion
2023-06-18

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05831683 on ClinicalTrials.gov